| Literature DB >> 17868390 |
J Cheng1, D Y Han, P Dai, H J Sun, R Tao, Q Sun, D Yan, W Qin, H Y Wang, X M Ouyang, S Z Yang, J Y Cao, G Y Feng, L L Du, Y Z Zhang, S Q Zhai, W Y Yang, X Z Liu, L He, H J Yuan.
Abstract
We report here the clinical, genetic, and molecular characteristics of a large Chinese family exhibiting non-syndromic, late-onset autosomal dominant sensorineural hearing loss. Clinical evaluation revealed variable phenotypes of hearing loss in terms of severity and age-at-onset of disease in these subjects. Genome-wide linkage analysis mapped the disease gene to the DFNA5 locus with a maximum two-point log odds score of 5.39 at [theta] = 0 for marker D7S2457. DNA sequencing of DFNA5 revealed a novel heterozygous IVS8+4 A>G substitution in the splice donor site of intron 8. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed skipping of exon 8 in the mutant transcript. This mutation faithfully cosegregated with hearing loss in the family. In addition, the mutation was absent in 100 unrelated control DNA samples of Chinese origin. The IVS8+4 A>G mutation is predicted to create a shift in the reading frame and introduce a stop codon at position 372, thereby resulting in a prematurely truncated DFNA5 protein. Up to date, a total of four mutations in DFNA5 have been reported to lead to hearing impairment, all of them result in skipping of exon 8 at the mRNA level. Our findings provide further support for the hypothesis that DFNA5-associated hearing loss is caused by a very specific gain-of-function mutation.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17868390 DOI: 10.1111/j.1399-0004.2007.00889.x
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438